Predictive Oncology Inc. (POAI)

USD 0.98

(0.15%)

Total Liabilities Summary of Predictive Oncology Inc.

  • Predictive Oncology Inc.'s latest annual total liabilities in 2023 was 6.14 Million USD , up 54.85% from previous year.
  • Predictive Oncology Inc.'s latest quarterly total liabilities in 2024 Q1 was 6.54 Million USD , up 6.54% from previous quarter.
  • Predictive Oncology Inc. reported annual total liabilities of 3.96 Million USD in 2022, up 13.21% from previous year.
  • Predictive Oncology Inc. reported annual total liabilities of 3.5 Million USD in 2021, down -66.35% from previous year.
  • Predictive Oncology Inc. reported quarterly total liabilities of 6.49 Million USD for 2024 Q2, down -0.83% from previous quarter.
  • Predictive Oncology Inc. reported quarterly total liabilities of 6.14 Million USD for 2023 FY, up 54.85% from previous quarter.

Annual Total Liabilities Chart of Predictive Oncology Inc. (2023 - 2008)

Historical Annual Total Liabilities of Predictive Oncology Inc. (2023 - 2008)

Year Total Liabilities Total Liabilities Growth
2023 6.14 Million USD 54.85%
2022 3.96 Million USD 13.21%
2021 3.5 Million USD -66.35%
2020 10.41 Million USD -6.52%
2019 11.14 Million USD 204.86%
2018 3.65 Million USD 292.08%
2017 932.34 Thousand USD -50.51%
2016 1.88 Million USD 23.96%
2015 1.51 Million USD -76.32%
2014 6.41 Million USD 68.35%
2013 3.81 Million USD 3.79%
2012 3.67 Million USD 16.62%
2011 3.14 Million USD 33.71%
2010 2.35 Million USD -10.52%
2009 2.63 Million USD 139.65%
2008 1.09 Million USD 0.0%

Peer Total Liabilities Comparison of Predictive Oncology Inc.

Name Total Liabilities Total Liabilities Difference
Akoya Biosciences, Inc. 126.59 Million USD 95.146%
AngioDynamics, Inc. 112.08 Million USD 94.517%
AtriCure, Inc. 147.76 Million USD 95.841%
Avinger, Inc. 19.97 Million USD 69.23%
Azenta, Inc. 351.22 Million USD 98.25%
BioLife Solutions, Inc. 75.05 Million USD 91.812%
The Cooper Companies, Inc. 4.1 Billion USD 99.85%
Daxor Corporation 858.75 Thousand USD -615.623%
Ekso Bionics Holdings, Inc. 16.31 Million USD 62.325%
Femasys Inc. 9.4 Million USD 34.645%
GlucoTrack, Inc. 1.7 Million USD -259.805%
Harvard Bioscience, Inc. 64.29 Million USD 90.441%
Hologic, Inc. 4.02 Billion USD 99.847%
ICU Medical, Inc. 2.25 Billion USD 99.727%
Intuitive Surgical, Inc. 2.04 Billion USD 99.699%
KORU Medical Systems, Inc. 8.1 Million USD 24.197%
LeMaitre Vascular, Inc. 48.87 Million USD 87.427%
Innovative Eyewear, Inc. 659.93 Thousand USD -831.222%
Innovative Eyewear, Inc. 659.93 Thousand USD -831.222%
Masimo Corporation 1.67 Billion USD 99.633%
Microbot Medical Inc. 3.82 Million USD -60.624%
Meihua International Medical Technologies Co., Ltd. 25.07 Million USD 75.494%
Merit Medical Systems, Inc. 1.12 Billion USD 99.453%
Nephros, Inc. 3.5 Million USD -75.434%
NovoCure Limited 783.63 Million USD 99.216%
NEXGEL, Inc. 4.78 Million USD -28.325%
NEXGEL, Inc. 4.78 Million USD -28.325%
Singular Genomics Systems, Inc. 86.46 Million USD 92.892%
OraSure Technologies, Inc. 52.17 Million USD 88.221%
Pro-Dex, Inc. 23.34 Million USD 73.673%
Pulse Biosciences, Inc. 16.44 Million USD 62.628%
Precision Optics Corporation, Inc. 6.84 Million USD 10.217%
QuidelOrtho Corporation 3.55 Billion USD 99.827%
Repligen Corporation 853.2 Million USD 99.28%
Sanara MedTech Inc. 29.28 Million USD 79.014%
STAAR Surgical Company 102.73 Million USD 94.018%
Sharps Technology, Inc. 3.85 Million USD -59.416%
Utah Medical Products, Inc. 7.14 Million USD 13.989%
DENTSPLY SIRONA Inc. 4.07 Billion USD 99.849%
Jin Medical International Ltd. 8.92 Million USD 31.138%